Conavi Medical Corp. (TSXV:CNVI)

Conavi Medical Cash Flow Statement

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022
Net Income	-16.19	-20.52	-43.62	-26.09	-11.87
Depreciation & Amortization	0.72	0.74	0.89	1.17	0.93
Other Amortization	0.07	0.07	0.09	0.12	0.16
Loss (Gain) From Sale of Assets	0.11	0.2	0.2	0.19	0.03
Asset Writedown & Restructuring Costs	-0.09	0.04	0.09	0.03	0.06
Loss (Gain) From Sale of Investments	-	-	-	-0.13	-
Stock-Based Compensation	0.61	0.44	0.26	0.62	1.18
Other Operating Activities	-4	-2.42	17.39	3	-0.03
Change in Accounts Receivable	0.39	0.69	0.06	-0.5	0.04
Change in Inventory	0.03	1.27	1.39	-0.04	-0.23
Change in Accounts Payable	-0.02	-4.84	2.45	1.92	0.19
Change in Unearned Revenue	-	-	-	0.18	0.02
Change in Other Net Operating Assets	-2.26	-0.79	0.63	-0.63	-0.33
Operating Cash Flow	-20.62	-25.1	-20.15	-19.98	-8.85
Capital Expenditures	-0.07	-0.07	-0.58	-0.69	-0.93
Sale (Purchase) of Intangibles	-0.21	-0.11	-0.27	-0.14	-0.16
Investment in Securities	-	-	-	0.13	-
Other Investing Activities	-	3.75	-	-	-
Investing Cash Flow	-0.29	3.57	-0.85	-0.69	-1.09
Short-Term Debt Issued	-	-	8.19	-	-
Long-Term Debt Issued	-	-	-	0.41	-
Total Debt Issued	-	-	8.19	0.41	-
Long-Term Debt Repaid	-	-1.53	-0.94	-1.43	-0.95
Net Debt Issued (Repaid)	-1.59	-1.53	7.26	-1.02	-0.95
Issuance of Common Stock	12.07	22.16	0.01	0	-
Other Financing Activities	6.3	6.3	-	-	-
Financing Cash Flow	16.79	26.94	7.26	30.25	12.98
Net Cash Flow	-4.12	5.41	-13.73	9.58	3.04
Free Cash Flow	-20.7	-25.17	-20.72	-20.66	-9.78
Free Cash Flow Margin	-2931.45%	-275.96%	-958.95%	-874.07%	-362.22%
Free Cash Flow Per Share	-0.32	-0.44	-3.36	-3.36	-1.59
Levered Free Cash Flow	-	-14.68	-16.88	-14.69	-
Unlevered Free Cash Flow	-	-7.38	-11.87	-11.16	-
Change in Working Capital	-1.85	-3.66	4.55	1.11	0.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.